GSA Capital Partners’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $564K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $222K | Sell |
|
|||||
|
2024
Q3 | $517K | Buy |
|
|||||
|
2024
Q2 | $263K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.27M | Sell |
|
|||||
|
2023
Q3 | $993K | Buy |
|
|||||
|
2023
Q2 | $979K | Sell |
|
|||||
|
2023
Q1 | $1.93M | Sell |
|
|||||
|
2022
Q4 | $2.03M | Sell |
|
|||||
|
2022
Q3 | $602K | Buy |
|
|||||
|
2022
Q2 | $484K | Buy |
|
|||||
|
2022
Q1 | $419K | Buy |
|
|||||
|
2021
Q4 | $353K | Buy |
|
|||||
|
2021
Q3 | $336K | Buy |
|
|||||
|
2021
Q2 | $203K | Sell |
|
|||||
|
2021
Q1 | $377K | Sell |
|
|||||
|
2020
Q4 | $412K | Buy |
|
|||||
|
2020
Q3 | $63K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $103K | Sell |
|
|||||
|
2018
Q3 | $368K | Sell |
|
|||||
|
2018
Q2 | $534K | Buy |
|